NCT05621889RecruitingPhase 1/2
Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer
Impacts of an Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model to Prevent Swallowing Disorders in Patients Treated With Chemoradiotherapy for Head and Neck Cancer
Source: ClinicalTrials.gov · Last updated 21 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This project aims to study an innovative intervention, the eG2 Intervention, developed by speech-language pathologists at the Centre hospitalier de l'Université de Montréal to improve therapeutic adherence and prevent dysphagia in patients treated with chemoradiotherapy for head and neck cancer. The innovation consists in offering a speech therapy intervention that is 1) virtual, 2) group-based (whereas it is usually individual) and 3) involves a patient partner. This intervention has the potential to improve quality of care, accessibility to services and optimize health care resources.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- First submitted
- 11 Nov 2022
- Start date
- 2 Jun 2023
- Primary completion date
- Jan 2026
- Lead sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Diseases
- Head and neck cancer
- NCT number
- NCT05621889
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 76
- From 2 Jun 2023 to the primary completion date, Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous or planned total laryngectomy
- Previous moderate/severe dysphagia known and/or evaluated by speech therapy
- History of prior radiation therapy to the head and neck area
Other illness
- Diagnosis of a second synchronous cancer at the time of study enrollment
- Have a cognitive impairment (diagnosed or suspected) that may significantly interfere with participation in the intervention and various measurement procedures.
Other
- Remote metastases
Who the study is looking for
- Adults ≥ 18 years of age with a diagnosis of head or neck cancer
- Chemoradiotherapy treatments planned for curative purposes
- Planned external radiation therapy dose of at least ≥60 Grays
- Sufficient proficiency in French to complete self-reported questionnaires
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier de l'Université de Montréal Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.